Sex differences in coronary plaque stabilization with evolocumab: a post hoc analysis of the YELLOW III trial. (PubMed, Int J Cardiovasc Imaging) - Sep 6, 2026 - "Evolocumab was associated with similar short-term plaque stabilization in women and men with CCD, despite baseline sex-related differences in inflammatory pathways. These findings warrant confirmation in larger prospective studies."
Journal • Retrospective data • Cardiovascular • Dyslipidemia
|
|
Amit Hooda; Annapoorna S Kini; Jagat Narula; Jiajia Liu; Joseph Sweeny; Keisuke Yasumura; Pedro Moreno; Prakash Krishnan; Pruthvi C Revaiah; Raman Sharma; Roxana Mehran; Sahil Khera; Samin Sharma; Sarah Goldman; Vishal Kapur; Xiaobo Zhou; Yuliya Vengrenyuk
|